Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Quadriga BioSciences

Quadriga BioSciences
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$7.84M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a cancer treatment technology intended to develop personalized medicine for cancer treatment. The company's technology develop novel targeted molecules against cancer cells that over-express certain unique amino acid transporters on their cell surfaces for the intake of nutrients to support rapid tumor growth and proliferation, enabling professionals to deliver safe and effective treatments for patients with cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • 339 South San Antonio Road
  • Suite 2A
  • Los Altos, CA 94022
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Quadriga BioSciences’s full profile, request a free trial.

Quadriga BioSciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 20-Oct-2017 $7.84M 000 000.00 Completed Startup
6. Grant 01-Jan-2017 00.000 00.00 Completed Startup
5. Seed Round 05-Feb-2015 00.00 00.00 00.00 Completed Startup
4. Grant 01-Jun-2013 00000 Completed Startup
3. Debt - General Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Quadriga BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A-2 000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Series A-1 1,741,234 $0.002000 $0.17 $2.14 $2.14 1x $2.14 0%
Seed 901,904 $0.002000 $1.4 $1.4 1x $1.4 8.94%
To view this company’s complete Cap Table, request access »

Quadriga BioSciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3E Bioventures Capital Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
StartX Not-For-Profit Venture Capital Minority 000 0000 000000 0

Quadriga BioSciences Executive Team (7)

Name Title Board
Seat
Contact
Info
Gordon Ringold Ph.D Chief Executive Officer & Board Member
Peter Tam Chief Operating Officer, President, Secretary & Board Member
Wolf-Nicolas Fischer Ph.D Co-Founder & Vice President, Biology
Berndt Jandeleit Ph.D Co-Founder, Vice President, Chemistry & Board Member
Kerry Koller Ph.D Co-Founder, Vice President, Molecular Pharmacology & Board Member

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

Quadriga BioSciences Board Members (7)

Name Representing Role Since Contact
Info
Berndt Jandeleit Ph.D Quadriga BioSciences Co-Founder, Vice President, Chemistry & Board Member 000 0000
Gordon Ringold Ph.D Quadriga BioSciences Chief Executive Officer & Board Member 000 0000
Karen Liu Ph.D 3E Bioventures Capital Board Member 000 0000
Kerry Koller Ph.D Quadriga BioSciences Co-Founder, Vice President, Molecular Pharmacology & Board Member 000 0000
Lee Babiss Ph.D Quadriga BioSciences Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »